Novartis sickle-cell drug gets U.S. FDA approval
Novartis on Friday won U.S.
approval for its experimental sickle cell disease drug, making
it the first of several proposed new therapies designed to offer
lasting relief for patients with the debilitating blood disease
to get U.S. regulatory clearance.
approval for its experimental sickle cell disease drug, making
it the first of several proposed new therapies designed to offer
lasting relief for patients with the debilitating blood disease
to get U.S. regulatory clearance.
Posted by Reuters
